Skip to main content

Conditions of publication

Agree to conditions of submission, BioMed Central's copyright and license agreement and article-processing charge (APC)

Copyright and license agreement

During submission, you will need to accept and confirm the following conditions:

  • All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria
  • That the article is original, has not already been published in a journal, and is not currently under consideration by another journal
  • That you agree to the terms of the BioMed Central Copyright and License Agreement, which we strongly recommend you read and, where applicable, Open Data policy. For authors who are prevented from being the copyright holder (for instance where Crown Copyright applies or researchers are US government employees), BioMed Central can accommodate non-standard copyright lines. If this applies to you, please contact us and provide details of your situation.

For more information see our Copyright and license policy.

Article-processing charge
An article-processing charge (APC) applies for each article accepted for publication in Molecular Neurodegeneration . For further details please see our article-processing-charge page.

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    15.1 - 2-year Impact Factor
    15.8 - 5-year Impact Factor
    3.022 - SNIP (Source Normalized Impact per Paper)
    5.158 - SJR (SCImago Journal Rank)

    2022 Speed
    17 days submission to first editorial decision for all manuscripts (Median)
    124 days submission to accept (Median)

    2022 Usage 
    1,213,867 downloads
    4,511 Altmetric mentions 

Contact the Managing Editorial Team

Hongmei Li 

Lucy Job 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline